Camelford, United Kingdom

Anthony William Sibley

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Janssen Pharmaceutica Nv. Active years: 2006.


% Patents Active = 100.0


Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2006

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Inventor Spotlight: Anthony William Sibley

Introduction

Anthony William Sibley is a notable inventor based in Camelford, Great Britain. With a keen focus on pharmaceuticals, he has made significant contributions to the field, evidenced by his patent, which highlights his innovative spirit and dedication to advancing medical science.

Latest Patents

Sibley holds a patent for "2,4,5-trisubstituted thiazolyl derivatives and their anti-inflammatory activity." This invention involves the use of a compound designed to manufacture a medicament for the prevention or treatment of diseases mediated through TNF-α and/or IL-12. The compound features complex structural elements, including various substitutions on thiazolyl derivatives that enhance its therapeutic potential.

Career Highlights

He currently works at Janssen Pharmaceutica NV, a company renowned for its advancements in medical research and pharmaceutical products. His role has allowed him to contribute to significant pharmaceutical innovations, particularly in anti-inflammatory medications, which have wide-reaching implications for patient care.

Collaborations

Throughout his career, Sibley has collaborated closely with esteemed colleagues, including Christopher John Love and Jean Pierre Frans Van Wauwe. These partnerships emphasize the collaborative nature of innovation in the pharmaceutical industry and highlight Sibley's integration into a network of accomplished professionals.

Conclusion

Anthony William Sibley's work exemplifies the impact that dedicated inventors can have on healthcare and medicine. His patent not only underscores his innovative contributions but also reflects the ongoing advancements being made in the fight against diseases influenced by harmful proteins. As he continues his work at Janssen Pharmaceutica NV, the medical community eagerly anticipates further breakthroughs from this inventive mind.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…